Brian F. Gilmore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Brian F. Gilmore has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
John Migaly
Department of Surgery, Duke University Medical Center, Durham, North Carolina
5 shared publications- Brian Ezekian
Department of Surgery, Duke University Medical Center, Durham, NC, USA
3 shared publications - Harold J. Leraas
Department of Surgery, Duke University Medical Center, Durham, North Carolina
3 shared publications Andrew Barbas
Duke University Medical Center
2 shared publications- Andrew C. Peterson
Duke University Medical Center, Durham, NC
2 shared publications Brian Ezekian
Department of Surgery, Duke University, Durham, NC, USA
2 shared publications
Latest Publications
- 13 January 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (1) , e18
Predicting the future caretakers of traumatic vascular injury management via operative exposure among surgical trainees
- 13 January 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (1) , e18
Predicting the future caretakers of traumatic vascular injury management via operative exposure among surgical trainees
- 6 August 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 81 (1) , 97-102
Predicting the future caretakers of traumatic vascular injury management via operative exposure among surgical trainees
- 6 August 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 81 (1) , 97-102
Predicting the future caretakers of traumatic vascular injury management via operative exposure among surgical trainees
- 1 June 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (6) , e010374
Temporal Trends and Outcomes of Abdominal Aortic Aneurysm Care in the United States
BACKGROUND: Endovascular aortic aneurysm repair (EVAR) has had a dynamic impact on abdominal aortic aneurysm (AAA) care, often supplanting open AAA repair (OAR). Accordingly, US AAA management is often highlighted by disparities in patient selection and guideline compliance. The purpose of this analysis was to define secular trends in AAA care. METHODS: The Society for Vascular Surgery Vascular Quality Initiative was queried for all EVARs and OARs (2011–2021). End points included procedure utilization, change in mortality, patient risk profile, Society for Vascular Surgery-endorsed diameter compliance, off-label EVAR use, cross-clamp location, blood loss, in-hospital complications, and post-EVAR surveillance missingness. Linear regression was used without risk adjustment for all end points except for mortality and complications, for which logistic regression with risk adjustment was used. RESULTS: In all, 66 609 EVARs (elective, 85% [n=55 805] and nonelective, 15% [n=9976]) and 13 818 OARs (elective, 70% [n=9706] and nonelective, 30% [n=4081]) were analyzed. Elective EVAR:OAR ratios were increased (0.2 per year [95% CI, 0.01–0.32]), while nonelective ratios were unchanged. Elective diameter threshold noncompliance decreased for OAR (24%→17%; P =0.01) but not EVAR (mean, 37%). Low-risk patients increasingly underwent elective repairs (EVAR, +0.4%per year [95% CI, 0.2–0.6]; OAR, +0.6 points per year [95% CI, 0.2–1.0]). Off-label EVAR frequency was unchanged (mean, 39%) but intraoperative complications decreased (0.5% per year [95% CI, 0.2–0.9]). OAR complexity increased reflecting greater suprarenal cross-clamp rates (0.4% per year [95% CI, 0.1–0.8]) and blood loss (33 mL/y [95% CI, 19–47]). In-hospital complications decreased for elective (0.7% per year [95% CI, 0.4–0.9]) and nonelective EVAR (1.7% per year [95% CI, 1.1–2.3]) but not OAR (mean, 42%). A 30-day mortality was unchanged for both elective OAR (mean, 4%) and EVAR (mean, 1%). Among nonelective OARs, an increase in both 30-day (0.8% per year [95% CI, 0.1–1.5]) and 1-year mortality (0.8% per year [95% CI, 0.3–1.6]) was observed. Postoperative EVAR surveillance acquisition decreased (67%→49%), while 1-year mortality among patients without imaging was 4-fold greater (9.2% versus imaging, 2.0%; odds ratio, 4.1 [95% CI, 3.8–4.3]; P <0.0001). CONCLUSIONS: There has been an increase in EVAR and a corresponding reduction in OAR across the United States, despite established concerns surrounding guideline adherence, reintervention, follow-up, and cost. Although EVAR morbidity has declined, OAR complication rates remain unchanged and unexpectedly high. Opportunities remain for improving AAA care delivery, patient and procedure selection, guideline compliance, and surveillance.
- 1 June 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (6) , e010374
Temporal Trends and Outcomes of Abdominal Aortic Aneurysm Care in the United States
BACKGROUND: Endovascular aortic aneurysm repair (EVAR) has had a dynamic impact on abdominal aortic aneurysm (AAA) care, often supplanting open AAA repair (OAR). Accordingly, US AAA management is often highlighted by disparities in patient selection and guideline compliance. The purpose of this analysis was to define secular trends in AAA care. METHODS: The Society for Vascular Surgery Vascular Quality Initiative was queried for all EVARs and OARs (2011–2021). End points included procedure utilization, change in mortality, patient risk profile, Society for Vascular Surgery-endorsed diameter compliance, off-label EVAR use, cross-clamp location, blood loss, in-hospital complications, and post-EVAR surveillance missingness. Linear regression was used without risk adjustment for all end points except for mortality and complications, for which logistic regression with risk adjustment was used. RESULTS: In all, 66 609 EVARs (elective, 85% [n=55 805] and nonelective, 15% [n=9976]) and 13 818 OARs (elective, 70% [n=9706] and nonelective, 30% [n=4081]) were analyzed. Elective EVAR:OAR ratios were increased (0.2 per year [95% CI, 0.01–0.32]), while nonelective ratios were unchanged. Elective diameter threshold noncompliance decreased for OAR (24%→17%; P =0.01) but not EVAR (mean, 37%). Low-risk patients increasingly underwent elective repairs (EVAR, +0.4%per year [95% CI, 0.2–0.6]; OAR, +0.6 points per year [95% CI, 0.2–1.0]). Off-label EVAR frequency was unchanged (mean, 39%) but intraoperative complications decreased (0.5% per year [95% CI, 0.2–0.9]). OAR complexity increased reflecting greater suprarenal cross-clamp rates (0.4% per year [95% CI, 0.1–0.8]) and blood loss (33 mL/y [95% CI, 19–47]). In-hospital complications decreased for elective (0.7% per year [95% CI, 0.4–0.9]) and nonelective EVAR (1.7% per year [95% CI, 1.1–2.3]) but not OAR (mean, 42%). A 30-day mortality was unchanged for both elective OAR (mean, 4%) and EVAR (mean, 1%). Among nonelective OARs, an increase in both 30-day (0.8% per year [95% CI, 0.1–1.5]) and 1-year mortality (0.8% per year [95% CI, 0.3–1.6]) was observed. Postoperative EVAR surveillance acquisition decreased (67%→49%), while 1-year mortality among patients without imaging was 4-fold greater (9.2% versus imaging, 2.0%; odds ratio, 4.1 [95% CI, 3.8–4.3]; P <0.0001). CONCLUSIONS: There has been an increase in EVAR and a corresponding reduction in OAR across the United States, despite established concerns surrounding guideline adherence, reintervention, follow-up, and cost. Although EVAR morbidity has declined, OAR complication rates remain unchanged and unexpectedly high. Opportunities remain for improving AAA care delivery, patient and procedure selection, guideline compliance, and surveillance.
- 1 July 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 74, 511-514
Retrograde Transamputation Revascularization: A Case Report
- 1 July 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 74, 511-514
Retrograde Transamputation Revascularization: A Case Report
- 1 May 2021
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 9 (3) , 712-719
Gonadal vein transposition is a safe and effective treatment of nutcracker syndrome
- 1 May 2021
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 9 (3) , 712-719
Gonadal vein transposition is a safe and effective treatment of nutcracker syndrome
- 1 March 2021
- Published by Elsevier in Journal of Surgical Education
- Vol. 78 (2) , 382-385
A Novel Model for a Student-Led Surgical Anatomy Seminar
- 1 March 2021
- Published by Elsevier in Journal of Surgical Education
- Vol. 78 (2) , 382-385
A Novel Model for a Student-Led Surgical Anatomy Seminar
- 29 August 2020
- Published by Springer Nature
- p. 1067-1078
Elderly Donors in Transplantation
- 28 February 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (1) , 275-290
Evolution of minimally invasive surgery for rectal cancer: update from the national cancer database
Background As the use of minimally invasive techniques in colorectal surgery has become increasingly prevalent, concerns remain about the oncologic effectiveness and long-term outcomes of minimally invasive low anterior resection (MI-LAR) for the treatment of rectal cancer. Study design The 2010–2015 National Cancer Database (NCDB) Participant Data Use File was queried for patients undergoing elective open LAR (OLAR) or MI-LAR for rectal adenocarcinoma. A 1:1 propensity match was performed on the basis of demographics, comorbidity, and tumor characteristics. Outcomes were compared between groups and Cox proportional hazard modeling was performed to identify independent predictors of mortality. A subset analysis was performed on high-volume academic centers. Results 35,809 patients undergoing LAR were identified of whom 18,265 (51.0%) underwent MI-LAR. After propensity matching, patients receiving MI-LAR were less likely to have a positive circumferential radial margin (CRM) (5.5% vs. 6.6%, p = 0.0094) or a positive distal margin (3.6% vs. 4.6%, p = 0.0022) and had decreased 90-day all-cause mortality (2.0% vs. 2.6%, p = 0.0238). MI-LAR resulted in decreased hospital length of stay (5 vs. 6 days, p < 0.0001) but a greater rate of 30-day readmission (7.6% vs. 6.5%, p = 0.0054). Long-term overall survival was improved with MI-LAR (79% vs. 76%, p < 0.0001). Cox proportional hazard modeling demonstrated a decreased risk of mortality with MI-LAR (HR 0.859, 95% CI 0.788–0.937). Conclusion MI-LAR is associated with improvement in CRM clearance and long-term survival. In the hands of experienced surgeons with advanced laparoscopy skills, MI-LAR appears safe and effective technique for the management of rectal cancer.
- 28 February 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (1) , 275-290
Evolution of minimally invasive surgery for rectal cancer: update from the national cancer database
Background As the use of minimally invasive techniques in colorectal surgery has become increasingly prevalent, concerns remain about the oncologic effectiveness and long-term outcomes of minimally invasive low anterior resection (MI-LAR) for the treatment of rectal cancer. Study design The 2010–2015 National Cancer Database (NCDB) Participant Data Use File was queried for patients undergoing elective open LAR (OLAR) or MI-LAR for rectal adenocarcinoma. A 1:1 propensity match was performed on the basis of demographics, comorbidity, and tumor characteristics. Outcomes were compared between groups and Cox proportional hazard modeling was performed to identify independent predictors of mortality. A subset analysis was performed on high-volume academic centers. Results 35,809 patients undergoing LAR were identified of whom 18,265 (51.0%) underwent MI-LAR. After propensity matching, patients receiving MI-LAR were less likely to have a positive circumferential radial margin (CRM) (5.5% vs. 6.6%, p = 0.0094) or a positive distal margin (3.6% vs. 4.6%, p = 0.0022) and had decreased 90-day all-cause mortality (2.0% vs. 2.6%, p = 0.0238). MI-LAR resulted in decreased hospital length of stay (5 vs. 6 days, p < 0.0001) but a greater rate of 30-day readmission (7.6% vs. 6.5%, p = 0.0054). Long-term overall survival was improved with MI-LAR (79% vs. 76%, p < 0.0001). Cox proportional hazard modeling demonstrated a decreased risk of mortality with MI-LAR (HR 0.859, 95% CI 0.788–0.937). Conclusion MI-LAR is associated with improvement in CRM clearance and long-term survival. In the hands of experienced surgeons with advanced laparoscopy skills, MI-LAR appears safe and effective technique for the management of rectal cancer.
- 1 December 2019
- Published by Elsevier in Seminars in Colon and Rectal Surgery
- Vol. 30 (4) , 100707
New innovations in anal fistula surgery
- 1 December 2019
- Published by Elsevier in Seminars in Colon and Rectal Surgery
- Vol. 30 (4) , 100707
New innovations in anal fistula surgery
- 1 March 2019
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 54 (3) , 507-510
Outcomes of laparoscopic resection of Meckel's diverticulum are equivalent to open laparotomy
- 1 March 2019
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 54 (3) , 507-510
Outcomes of laparoscopic resection of Meckel's diverticulum are equivalent to open laparotomy